[Carotinoid retinopathy. III. Reversibility].

Abstract

Twenty-five patients (erythropoietic protoporphyria 23, polymorphous light eruption 1, "cosmetics" 1) were re-examined 2-10 months after therapy with beta-carotene and canthaxanthine was discontinued. Dark adaptation and ERG parameters had normalized, whereas crystalline retinopathy and pigment epithelial defects showed no signs of reversibility.

• Authors: U Weber, G Goerz
• Journal: Klinische Monatsblatter fur Augenheilkunde (Klin Monbl Augenheilkd) Vol. 188 Issue 1 Pg. 20-2 (Jan 1986) ISSN: 0023-2165 [Print] Germany
• Vernacular Title: Carotinoid-Retinopathie. III. Reversibilität.
• PMID: 3959472 (Publication Type: English Abstract, Journal Article)

Chemical References

• Drug Combinations
• Porphyrins
• Protoporphyrins
• beta Carotene
• Carotenoids
• Canthaxanthin
• phenoro

Topics

• Canthaxanthin
• Carotenoids (adverse effects, analogs & derivatives, therapeutic use)
• Dose-Response Relationship, Drug
• Drug Combinations (adverse effects, therapeutic use)
• Electroretinography
• Fluorescein Angiography
• Follow-Up Studies
• Humans
• Photosensitivity Disorders (drug therapy)
• Porphyrias (drug therapy)
• Porphyrins (blood)
• Protoporphyrins (blood)
• Retinal Diseases (chemically induced)
• Skin Diseases (drug therapy)
• beta Carotene